Walking the Genetic Line

Natalie Samson Hart: How Integrative Genetic Counseling Changes What Comes Next

Guest: Natalie Samson Hart, MS, CGC, INHC Theme: Genetic Counseling as a Gateway to Whole-Person Care Episode Summary Natalie Samson Hart didn't come to oncology genetic counseling through a tidy career trajectory. She came through loss, confusion, and proximity to illness — a brother whose neurodivergence led her toward the intersection of science and human connection, a father diagnosed with stage 4 cancer while she was still in graduate school and rotating through cancer wards. That collision of the personal and professional is what eventually pushed her out of traditional hospital settings and toward founding Golden Genetics, a practice built on the premise that a six-page genetic report means almost nothing without the relational and integrative context to hold it. What surfaces throughout this conversation is a tension most patients never get to name: the difference between receiving information and actually being able to use it. Natalie speaks to the quiet crisis that happens after the second genetic counseling appointment — when results have been delivered, the portal notification sits unread, and no one has called to ask if the patient actually scheduled the surgery or the screening. It's in that gap — between knowing and doing, between information and integration — that the real work lives. And it's exactly where the standard model fails. We Cover • The Genetic Counseling Pre-Test Gap: Why seeing a genetic counselor before testing — not just after — changes everything, and how the absence of pre-test counseling leaves patients blindsided by results they never chose to receive. • Negative Results and Unresolved Grief: The counterintuitive psychological weight of a negative genetic test when cancer runs deep in a family: a lack of answer, not a clean bill of health. • Agency as Trauma Prevention: How the way genetic information is delivered — with or without relational attunement, with or without patient choice — can be the difference between a neutral medical event and a traumatizing one. • The Responsibility Reflex in Risk Management: Why patients who "eat perfectly" and do all the right things are often the most overwhelmed, and how perfectionism around cancer prevention can itself become a source of chronic stress and nervous system dysregulation. • Integrative Genetic Counseling vs. Standard Care: How Natalie's practice at Golden Genetics adds nutrigenomics, lifestyle counseling, and longitudinal follow-up to expand what genetic counseling can hold. • The Siloed Care Problem: The systemic gap when oncologists, genetic counselors, therapists, and integrative practitioners don't talk to each other — and what it costs patients who are left playing telephone between providers. • Who Should Pursue Genetic Counseling: Concrete indicators for cancer genetic testing — family history patterns, age of diagnosis, related cancer types — alongside a broader call for early, proactive genetic literacy. • Nutrigenomics and the Systems Biology Approach: What it means to look at low-risk genes not in isolation but in relationship to each other — including a clear-eyed correction of common MTHFR misinformation. Highlights & Takeaways • A positive genetic result can function as a permission slip — releasing blame, opening insurance access, and paradoxically restoring a sense of agency. A negative result, when cancer saturates a family, can land as a lack of answer rather than a relief. • The behavior matters less than what's driving it. If cancer prevention practices are rooted in self-punishment and fear rather than self-alliance, the nervous system is registering threat regardless of how clean the diet is. • The genetic counselor stands at the gateway — not to sort patients into risk categories, but to offer them enough information to make an actual choice about whether they want to know more. No one should have to receive life-altering results they never consented to receiving. • The real work often happens after the second appointment. When the portal sits unopened and the surgery goes unscheduled, that's not avoidance or failure — it's a nervous system that hasn't been supported through the integration phase. • Genetic information can become a form of identity — a way of finally understanding something that felt like a flaw or a mystery about yourself. When interpreted carefully, that recognition can soften self-attack into self-understanding. Content Note This episode includes discussion of stage 4 cancer diagnosis and a parent's prognosis, the psychological weight of negative genetic test results in families with significant cancer history, and the emotional aftermath of receiving unexpected genetic information without adequate preparation. Listeners navigating their own recent diagnosis or test results may want to listen in smaller segments. Resources Mentioned Guest Resources • Golden Genetics: Natalie's integrative genetic counseling practice. Website: goldengeneticshealth.com | Email: info@goldengeneticshealth.com | Book a call through the website. Standard Resources • Face the Risk Together Support Groups: sarachampielcsw.com • FORCE (Facing Our Risk of Cancer Empowered): facingourrisk.org — national organization for hereditary cancer advocacy and peer support • National Society of Genetic Counselors (NSGC): nsgc.org — find a certified genetic counselor for hereditary cancer risk Connect If this conversation resonates, follow, rate, and share the show. Find Sara Champie on IG @SaraChampieLCSW and sarachampielcsw.com for free resources and access to 1:1 and group support. You already speak this language — come walk the genetic line with us. Sara Champie

Krista Brown: ATM Mutation, Delayed Diagnosis, and What Self-Advocacy Actually Costs

Guest: Krista (Oncology Nurse Navigator) Theme: Self-Advocacy, ATM Mutation, Cancer After Previvorhood EPISODE SUMMARY When Krista's mother was 48, she became the first known cancer diagnosis in their family. She tested negative for BRCA mutations and felt relief — relief that she wouldn't pass anything on to her children. Twelve years later, just before entering hospice, she was offered expanded genetic testing and found out she carried a pathogenic ATM variant. She shared those results with her children. A few months after her death, Krista — 38 years old, a nurse, carrying twelve years of hospital vigils and treatment complications in her body — went in and requested her own testing. What unfolds from that appointment is a story about what it actually takes to move through a healthcare system that doesn't know your mutation, that tells you the abnormality on your MRI is a lymph node, that sends you home with "come back in six months." Krista pushed for a biopsy that three specialists told her she didn't need. She was right. Her cancer diagnosis arrived two weeks before her scheduled preventive surgery. She now works as an oncology nurse navigator, walks patients through the same system she had to fight, and has built an educational platform for the hereditary cancer community — shaped entirely by what she wasn't told when she needed it most. WE COVER * Testing too late, too little: Why Krista — a nurse with two generations of breast cancer in her family — was never offered genetic testing for twelve years, and what that delay meant for her outcomes. * The self-advocacy paradox: The tension of knowing something is wrong, having a medical background, identifying as a people-pleaser, and still having to push three specialists who said she was overreacting. * ATM mutation specifics: What carriers of ATM pathogenic variants actually face — including a 69% breast cancer risk, pancreatic and ovarian risk, and why the focus on BRCA leaves ATM carriers navigating without a map. * The middle phase nobody prepares you for: The psychological and bodily experience of bilateral mastectomy with flap reconstruction between the first and second surgery — including what it does to a woman's relationship with her own reflection. * Explaining hereditary cancer to children: How Krista told her daughters (ages 5, 8, and 10 at diagnosis) about her mutation, her surgery, and later her cancer — including what she had to process in herself first before she could speak from a calm place. * The grief that doesn't announce itself: How choosing surgery — a choice she felt grateful for — still produced grief she felt she wasn't allowed to have, and why "I chose this" doesn't close off mourning. * Cancer as identity reorganizer: How the experience shifted what Krista allows into her life, where she places her attention, and what felt insufficient about who she'd been before this began. * What the oncology system still misses: How even inside treatment, secondary risks (pancreatic, ovarian) get dropped after the primary intervention, and why mutation carriers need to track their full risk profile across specialties. HIGHLIGHTS & TAKEAWAYS * Three specialists told her the abnormality wasn't cancer. She pushed anyway. That instinct — the unsettled feeling she couldn't explain — was the most accurate clinical information she had. Learning to trust it required overriding the authority gradient we're all trained to defer to. * The grief of choosing surgery is still grief. Knowing you're lucky, knowing you have options, knowing what you avoided — none of that neutralizes what it costs to look in the mirror at a body mid-reconstruction and not recognize yourself. Gratitude and loss occupy the same moment. * What she modeled for her daughters wasn't resilience. It was legibility — making the emotional experience visible and speakable so it could move through them instead of getting stored somewhere unnamed. * The shift from previvor to cancer diagnosis didn't happen at diagnosis. It had been accumulating across twelve years of watching her mother, then across the months of self-advocacy, then across a two-week window between a positive biopsy and surgery already on the calendar. The "before and after" is rarely a single moment. * She found her way into the hereditary cancer community not as someone who sought support, but as someone who had always been "fine." The connection she found there changed more than her career — it changed what she understood about what she'd actually needed all along. CONTENT NOTE This episode includes detailed discussion of a parent's cancer diagnosis and death, including end-of-life care and hospice. Krista also shares her own cancer diagnosis and surgical experience, including the psychological impact of bilateral mastectomy with reconstruction. The conversation includes reference to the loss of a sister-in-law to cancer at age 38. RESOURCES MENTIONED Guest resources: * Krista on Instagram: @cancer.prevention.coach — hereditary cancer education and advocacy content for the ATM and broader high-risk community Standard links: * Face the Risk Together support groups: sarachampielcsw.com * FORCE (Facing Our Risk of Cancer Empowered): facingourrisk.org — national organization for hereditary cancer advocacy and peer support * National Society of Genetic Counselors (NSGC): nsgc.org — find a certified genetic counselor for hereditary cancer risk CONNECT If this conversation resonates, follow, rate, and share the show. Find Sara Champie on IG @sarachampielcsw and sarachampielcsw.com for free resources and access to 1:1 and group support. You already speak this language — come walk the genetic line with us. Sara Champie

Ali Hall: Prophylactic Mastectomy, Queer Identity, and Claiming Your Body on Your Own Terms

_*]:min-w-0 gap-3"> Guest: Ali Hall Theme: Queer Identity, Bodily Autonomy, and the BRCA Diagnosis Nobody Saw Coming _*]:min-w-0 gap-3"> _*]:min-w-0 gap-3"> Episode Summary _*]:min-w-0 gap-3"> When Ali Hall stole a 23andMe kit from a family white elephant exchange, she wasn't looking for anything life-changing. Five years later, an email arrived while she was picking her kid up from school: her results had been updated. She had a BRCA mutation. What followed wasn't panic — and that itself is the story. Ali's response was shaped by something older than the diagnosis: a lifelong pattern of minimizing her own experience when people around her were suffering more visibly. _*]:min-w-0 gap-3"> What makes this conversation rare is the intersection Ali navigates without apology. As a queer, gender-expansive person living in Florida, going flat wasn't just a medical decision — it was a question of safety, identity, and what it finally meant to feel at home in her own body. Three weeks post-surgery, something unexpected happened: she stopped caring what other people thought. This episode sits at the crossroads of intergenerational emotional inheritance, bodily autonomy, and what it looks like when a medical intervention accidentally hands you the self-acceptance you were never quite given permission to claim. _*]:min-w-0 gap-3"> _*]:min-w-0 gap-3"> We Cover _*]:min-w-0 gap-3"> * The accidental diagnosis: How Ali discovered her BRCA mutation through a forgotten 23andMe test — and what it means to receive life-altering information you never sought out * Minimizing your own risk as a survival pattern: Why Ali's first response was "this isn't a big deal" — and how being surrounded by people with active cancer taught her, long before any lab result, that her experience counted less * Navigating prophylactic mastectomy in a queer body: The real safety calculations, identity considerations, and bodily autonomy questions that mainstream BRCA spaces don't make room for * The noise problem: How well-meaning but homogenized Facebook groups pushed Ali back toward her own body knowledge — and why returning to herself was the most important decision she made * Information, timing, and emotional maturity: Why Ali believes she made the right decision at exactly the right moment — and what she thinks happens when young people receive this diagnosis before they have the scaffolding to hold it * Going flat and gaining ground: What happened to Ali's confidence three weeks after surgery — and why it surprised her * The gap in hereditary cancer care: Why even world-class medical systems leave patients without trauma-informed emotional support after a BRCA diagnosis _*]:min-w-0 gap-3"> _*]:min-w-0 gap-3"> Highlights & Takeaways _*]:min-w-0 gap-3"> * Minimizing your own risk is a survival pattern, not a personality trait. When people around you have "real" cancer, your genetic warning can feel like it doesn't count — and that belief has roots long before the diagnosis arrives. * The body knows before the mind catches up. Ali knew she would go flat before she could fully articulate why. Fighting that knowledge — researching implants she never wanted — was the cost of not yet trusting herself. * Prophylactic surgery carries different stakes in a queer body. The decision wasn't just medical. It was a calculation about safety, visibility, and what kind of presence Ali could have in the world after surgery. * More information isn't always better. Ali raises a question this field rarely asks: what would have happened if she'd gotten this diagnosis at 25, before she had the emotional scaffolding to hold it? * Sometimes the medical intervention is the least disruptive part. The harder work was learning to stop abandoning herself in service of everyone else's comfort — a pattern the diagnosis finally cracked open. _*]:min-w-0 gap-3"> _*]:min-w-0 gap-3"> Content Note _*]:min-w-0 gap-3"> This episode discusses BRCA mutation, prophylactic mastectomy, queer identity and gender expression, bodily safety, parenting with genetic risk, and the emotional experience of unsought medical information. _*]:min-w-0 gap-3"> _*]:min-w-0 gap-3"> Resources Mentioned _*]:min-w-0 gap-3"> * FORCE (Facing Our Risk of Cancer Empowered): facingourrisk.org [https://www.facingourrisk.org] — national organization for hereditary cancer advocacy and peer support * Fierce Flat Community: peer support for those who choose to go flat after mastectomy * National Society of Genetic Counselors (NSGC): nsgc.org [https://www.nsgc.org] — find a certified genetic counselor for hereditary cancer risk * Face the Risk Together: Sara Champie's support groups for people in California: sarachampielcsw.com [http://www.sarachampielcsw.com] _*]:min-w-0 gap-3"> _*]:min-w-0 gap-3"> Connect _*]:min-w-0 gap-3"> If this conversation resonates, follow, rate, and share the show. Find Sara Champie on IG @FaceTheRiskTogether and sarachampielcsw.com [http://www.sarachampielcsw.com] for free resources and access to 1:1 and group support. _*]:min-w-0 gap-3"> You already speak this language — come walk the genetic line with us. _*]:min-w-0 gap-3"> _*]:min-w-0 gap-3">

Jennifer Mercer: Lynch Syndrome Awareness and the Weight of a Father's Legacy

Episode Summary Jennifer never knew her biological father growing up — and when she finally let him back into her life at 25, what he brought with him was a medical history that would change everything. Phone call after phone call, a new cancer. Eight-plus organ cancers. Over a hundred skin cancers. Years before anyone thought to offer him a genetic test. When Lynch Syndrome MSH2 was finally identified, Jennifer wasn't ready — she was a single mother, financially stretched, emotionally guarded, and carrying decades of unresolved grief toward a man who had never shown up for her. She put it on the shelf. And then he died. And she couldn't anymore. In this episode, Jennifer and Sara explore what it means to inherit a diagnosis from the parent who was already a wound — how the moment of receiving a positive result is a nervous system event as much as a medical one, and how rage, guilt, fear for your children, and grief for a father you never fully had can arrive all at once in a single Zoom call. Jennifer also shares how she transformed that convergence into Lynch Syndrome Awareness, an organization fighting to close the staggering gap between how common this mutation is — 1 in 279 — and how rarely doctors recognize it. We Cover * Growing up without her biological father and reconnecting at 25 — only to find a devastating medical history on the other side * Watching her father face eight-plus organ cancers over years, and the slow accumulation of fear that came with every phone call * The financial and emotional barriers that delayed her own testing — and why that delay deserves compassion, not judgment * Receiving her Lynch Syndrome MSH2 positive results by Zoom, alone, days before a family vacation — and what Time Collapse looks like in real time * The layered grief of inheriting a mutation from an absent parent: anger, guilt, and terror for her adult children arriving simultaneously * The Boland inversion — a rare MSH2 variant that has been missed by standard testing — and why naming it to your genetic counselor matters * Why Lynch Syndrome, the most common hereditary cancer mutation, remains almost entirely unknown to the general practitioners most likely to encounter it * The red flags that physicians can act on — cancer under 50, multiple primary cancers, family pattern — and the simple chart Jennifer's organization provides to help patients walk in prepared * Building Lynch Syndrome Awareness from personal crisis: what it looks like to turn inherited doom into community mission Highlights & Takeaways * "How dare you. Not a hug, not a birthday card — but this. You give this to me." Sometimes the mutation arrives from the parent who was already a loss. The grief is never only about cancer. * Avoidance after a family member's diagnosis is not denial — it is often the nervous system doing exactly what it needs to do when the load exceeds what the present moment can hold. * The moment of receiving a positive result is not just emotional. It is neurological. Jennifer's account of going numb, losing comprehension, and needing to end the call before she broke down is a clinical picture of what happens when past, present, and future collapse into one. * Lynch Syndrome affects 1 in 279 people — more than BRCA — and most doctors have never heard of it. Prevalence without visibility is its own kind of harm. * Self-advocacy is not a personality trait. It is a survival skill that patients can be taught, supported in, and given tools to practice. Content Note This episode includes discussion of paternal absence and estrangement, parental death, prolonged exposure to a family member's cancer illness, genetic testing and positive results, fear around children inheriting a mutation, financial barriers to genetic testing, and the emotional processing of hereditary cancer risk. Resources Mentioned * Lynch Syndrome Awareness — lynchsyndromeawareness.com [http://lynchsyndromeawareness.com/] * FORCE: Facing Our Risk of Cancer Empowered — facingourrisk.org — peer navigator program, message boards, and expert-reviewed resources for hereditary cancer * Genetic counseling services through comprehensive cancer centers * Trauma-informed therapy for individuals navigating hereditary cancer risk and intergenerational loss Connect If this episode resonated, please follow, rate, and share Walking the Genetic Line. Find Sara Champie on Instagram and TikTok @SaraChampieLCSW for trauma-informed resources, therapy offerings, and group support. You are not alone in this. Let's walk this line, together.

Solo Episode: Living with Hereditary Cancer and Risk in a Loud World

Host: Sara Champie, LCSW Theme: Navigating medical vulnerability, global instability, and nervous system overwhelm during hereditary cancer risk and treatment. Episode summary What happens when your body is healing, your life is medically uncertain, and the world around you feels like it's unraveling? In this solo episode, therapist Sara Champie explores a reality many people navigating hereditary cancer risk quietly experience: the nervous system strain of managing personal medical vulnerability while absorbing the constant noise of global crisis. When surgery, treatment, or high-stakes medical decisions coincide with political instability, violence in the news, and collective trauma, the body doesn't separate those experiences — it metabolizes them all at once. Sara offers a trauma-informed perspective on why everything can feel so intense during these seasons, and why that intensity is not a sign of weakness but evidence of a nervous system doing exactly what it was designed to do. This episode is an invitation to reclaim boundaries, reduce overwhelm, and protect the small sphere of influence that supports healing. We cover • The nervous system impact of healing from surgery or treatment during times of global instability • Why the body does not separate personal and collective threats • The layered stress of medical decisions, family dynamics, and cultural chaos • How trauma histories can amplify reactions during medical vulnerability • Why overwhelm, exhaustion, or emotional volatility during healing is physiologically normal • The concept of titrating exposure to news, social media, and external stress • Protecting your energy and nervous system while your body repairs itself Highlights & takeaways "Your nervous system is metabolizing everything it's exposed to." "When your body is physically vulnerable, everything in the world lands harder." "Intensity does not mean you're falling apart. Your system is doing its job." "Our bodies did not evolve for 24-hour global awareness layered on top of personal medical vulnerability." "Caring about the world does not require flooding yourself." "Sometimes the most responsible thing we can do is protect the small sphere we actually have influence over." Content note This episode references medical trauma, surgery recovery, violence in the news, political instability, sexual abuse systems, trauma history, and the emotional strain of living with hereditary cancer risk. Resources mentioned Walking the Genetic Line Podcast Conversations exploring the emotional, relational, and psychological realities of hereditary cancer risk. Sara Champie, LCSW Trauma-informed psychotherapist specializing in hereditary cancer risk, medical decision-making, and intergenerational healing. Website: https://sarachampielcsw.com Instagram: @sarachampielcsw Connect If this episode resonated, please consider following the show, leaving a review, or sharing it with someone navigating hereditary cancer risk or medical uncertainty. You can connect with Sara Champie and learn more about her work at @sarachampielcsw. Let's walk this line, together. Additional support If you are navigating genetic risk, cancer treatment, or complex medical decisions, trauma-informed therapy and support communities can help process the emotional layers that often accompany these experiences. Support may include: • Individual therapy • Support groups for individuals navigating genetic risk or cancer • Patient advocacy organizations and peer support networks You deserve care that addresses both the medical and emotional realities of this journey.